English

    Overview

  • Dr. Harsh Dhar is a Senior Consultant in the Department of Head and Neck Surgery at Manipal Hospitals, E.M Bypass, Kolkata, with an extensive background in the field of Head Neck Oncology and a reputation for clinical excellence. His academic journey began with an MBBS degree from a prestigious medical institution, followed by an MS in ENT and an MCh in Head and Neck Surgery from the prestigious Tata Memorial Hospital , Mumbai . In addition , he has also trained extensively in the field of Skull Base Surgery , with clinical observerships from Univ of Pittsburgh , USA and Univ of Brescia , Italy.

  • Dr. Dhar’s unwavering commitment to his field is evident from his multiple accolades, including a Gold Medal in Surgical Oncology (Batch of 2017) and Silver Medals in ENT and Internal Medicine as well as numerous publications during his academic tenure. His memberships in esteemed professional bodies such as the Foundation of Head and Neck Oncology, the Indian Society of Thyroid Surgeons, the Asia Pacific Thyroid Society, and the European Society of Medical Oncology underscore his dedication to staying at the forefront of advancements in head and neck surgery.

  • His expertise encompasses the treatment and surgical management of oral, salivary, thyroid, and sinonasal cancers, especially tumours of the skull base as well as paragangliomas. Locally advanced thyroid cancers and Endoscopic Skull base surgeries are his prime areas of expertise . With a commitment to bringing better care through technological advancements, he and his team are the first in the region to bring in intra operative nerve monitoring routinely in thyroid surgeries as well as establish a state of the art Skull Base surgical unit.

  • Beyond clinical practice, Dr. Dhar is passionate about education and within and is responsible for training many junior surgeons at his centre and through invited talks at national and regional conferences, contributing to knowledge dissemination in his specialty. With over a decade of experience, Dr. Dhar has become a trusted name in the management of complex oncological cases involving the head and neck region.

    • Field of Expertise

  • All Types of Head and Neck Malignancies
  • Thyroid Tumors

    • Fellowship & Membership

  • Member of the Foundation of Head and Neck Oncology
  • Member of the Indian Society of Thyroid Surgeons
  • Member of the Asia Pacific Thyroid Society
  • Member of the European Society of Medical Oncology

    • Languages Spoken

  • English
  • Hindi
  • Bengali
  • Marathi
  • Tamil

    • Awards & Achievements

  • Gold Medal in Surgical Oncology, Batch of 2017, Tata Memorial Hospital
  • Silver Medal in ENT, MBBS (III Year)
  • MUHS Silver Medicine in MS ENT
  • MGR Medical University Silver Medal in Internal Medicine -Batch of 2009

    • Talks & Publications

  • Dr. Dhar has actively contributed to clinical research, with a focus on Neoadjuvant Chemotherapy in Oral Malignancies. His work supports organ preservation strategies and improves the quality of life for cancer patients.
  • Lodha JV1, Dabholkar JP, Dhar H ; Fronto-ethmoid osteoma: addressing surgical challenges. J Postgrad Med. 2014 Apr-Jun;60(2):207-8. PMID:24823529.
  • Dhar H, Dabholkar JP, Kandalkar BM, Ghodke R. Primary thyroid schwannoma masquerading as a thyroid nodule. J Surg Case Rep. 2014 Sep 23;2014(9) PMID: 25249001.
  • Tuljapurkar V, Dhar H, Mishra A, Chakraborti S, Chaturvedi P, Pai PS. The Indian scenario of head and neck oncology – Challenging the dogmas. South Asian Journal of Cancer. 2016;5(3):105-110.
  • Vaish R, Dhar H, DCruz A K .“Beyond Me, Too”. Journal of Global Oncology 2, no. 4 (August 2016) 248-249.
  • Dandekar M, Tuljapurkar V, Dhar H, Panwar A, DCruz A K. Head and neck cancers in India. J Surg Oncol. 2017; 115:555–563.
  • Dhar H, Thiagarajan S . Anomalous Radial Artery Bifurcation – Case report of 2 cases encountered during Radial Artery Forearm Flap Harvest. Images in Surgery, 2017.
  • Dhar H, Deshmukh A. Basic Principles in Laser Surgery -Chapter in Handbook of Laser Surgery, published by Lumenis, October 2015.
  • Deshmukh A, Mair M, Dhar H Surgeries for Tongue Cancer -chapter in Atlas of Operative Surgical Oncology, 2016 (published by the Tata Memorial Hospital).
  • DCruz A K , Dhar H , Mair M , Stack B . Elective Neck Dissection in the Upper Aerodigestive Tract. Chapter in Journal of ENT Master Class special edition.
  • Dabholkar J, Sharma A, Virmani N, Dhar H. Management of benign laryngotracheal stenosis – A 5-year experience of Indian tertiary care setup. J Head Neck Physicians Surg 2018; 6:3542.
  • D'Cruz AK, Vaish R, Dhar H. Oral cancers: Current status. Oral Oncol. 2018 Dec; 87:64-69.
  • Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.Fatehi KS, Thiagarajan S, Dhar H, Purandare N, DCruz AK, Chaukar D, Laskar SG, Prabhash K, Rangarajan V.Auris Nasus Larynx. 2018 Dec 26. pii: S0385-8146(18)30620-5.
  • Thiagarajan S, Dhar H, Bhattacharjee A, et al. Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to NeoAdjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral Oncol. 2020;100:104455. doi:10.1016/j.oraloncology.2019.104455.
  • Dhar H, Vaish R, D'Cruz AK. Management of locally advanced oral cancers. Oral Oncol. 2020;105:104662. doi:10.1016/j.oraloncology.2020.104662.
  • Dhar, H., Thiagarajan, S., Yousuf, A. et al. Referral Practice for Radioactive Iodine Ablation. (RAI) after ATA guidelines 2015: results from a Tertiary Cancer Care Centre. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-05946-4.
  • Dhar H, Datta S. Experience of treating head and neck cancers in government and private health-care systems during the COVID-19 pandemic: A viewpoint with summary of existing guidelines. Cancer Res Stat Treat 2020;3, Suppl S1:123-6.
  • Balaji, A., Thiagarajan, S., Dhar, H. et al. The results of sequential swallowing assessments after total laryngectomy for laryngeal and hypopharyngeal malignancies. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-06105-5.
  • S Thiagarajan , A Yousuf , R Shetty , H Dhar , Y Mathur , D Nair , S Basu , A Patil , S Kane , S Ghosh-Laskar , D Chaukar. Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care centre . Eur Arch Otorhinolaryngol. 2020;277(6):1807‐1814.
  • Chapter: Elective Versus Therapeutic Neck Dissection for Clinically.Node Negative Early oral Cancer, D’Cruz A K, Dhar H, Vaish R .Difficult Decisions in Head and Neck Oncologic Surgery edited by Zhen Gooi, Nishant Agrawal, Springer 2019.

    Fellowship & Membership

  • Member of the Foundation of Head and Neck Oncology
  • Member of the Indian Society of Thyroid Surgeons
  • Member of the Asia Pacific Thyroid Society
  • Member of the European Society of Medical Oncology

    • Overview

  • Dr. Harsh Dhar is a Senior Consultant in the Department of Head and Neck Surgery at Manipal Hospitals, E.M Bypass, Kolkata, with an extensive background in the field of Head Neck Oncology and a reputation for clinical excellence. His academic journey began with an MBBS degree from a prestigious medical institution, followed by an MS in ENT and an MCh in Head and Neck Surgery from the prestigious Tata Memorial Hospital , Mumbai . In addition , he has also trained extensively in the field of Skull Base Surgery , with clinical observerships from Univ of Pittsburgh , USA and Univ of Brescia , Italy.

  • Dr. Dhar’s unwavering commitment to his field is evident from his multiple accolades, including a Gold Medal in Surgical Oncology (Batch of 2017) and Silver Medals in ENT and Internal Medicine as well as numerous publications during his academic tenure. His memberships in esteemed professional bodies such as the Foundation of Head and Neck Oncology, the Indian Society of Thyroid Surgeons, the Asia Pacific Thyroid Society, and the European Society of Medical Oncology underscore his dedication to staying at the forefront of advancements in head and neck surgery.

  • His expertise encompasses the treatment and surgical management of oral, salivary, thyroid, and sinonasal cancers, especially tumours of the skull base as well as paragangliomas. Locally advanced thyroid cancers and Endoscopic Skull base surgeries are his prime areas of expertise . With a commitment to bringing better care through technological advancements, he and his team are the first in the region to bring in intra operative nerve monitoring routinely in thyroid surgeries as well as establish a state of the art Skull Base surgical unit.

  • Beyond clinical practice, Dr. Dhar is passionate about education and within and is responsible for training many junior surgeons at his centre and through invited talks at national and regional conferences, contributing to knowledge dissemination in his specialty. With over a decade of experience, Dr. Dhar has become a trusted name in the management of complex oncological cases involving the head and neck region.

    • Field of Expertise

  • All Types of Head and Neck Malignancies
  • Thyroid Tumors

    • Languages Spoken

  • English
  • Hindi
  • Bengali
  • Marathi
  • Tamil

    • Awards & Achievements

  • Gold Medal in Surgical Oncology, Batch of 2017, Tata Memorial Hospital
  • Silver Medal in ENT, MBBS (III Year)
  • MUHS Silver Medicine in MS ENT
  • MGR Medical University Silver Medal in Internal Medicine -Batch of 2009

    • Talks & Publications

  • Dr. Dhar has actively contributed to clinical research, with a focus on Neoadjuvant Chemotherapy in Oral Malignancies. His work supports organ preservation strategies and improves the quality of life for cancer patients.
  • Lodha JV1, Dabholkar JP, Dhar H ; Fronto-ethmoid osteoma: addressing surgical challenges. J Postgrad Med. 2014 Apr-Jun;60(2):207-8. PMID:24823529.
  • Dhar H, Dabholkar JP, Kandalkar BM, Ghodke R. Primary thyroid schwannoma masquerading as a thyroid nodule. J Surg Case Rep. 2014 Sep 23;2014(9) PMID: 25249001.
  • Tuljapurkar V, Dhar H, Mishra A, Chakraborti S, Chaturvedi P, Pai PS. The Indian scenario of head and neck oncology – Challenging the dogmas. South Asian Journal of Cancer. 2016;5(3):105-110.
  • Vaish R, Dhar H, DCruz A K .“Beyond Me, Too”. Journal of Global Oncology 2, no. 4 (August 2016) 248-249.
  • Dandekar M, Tuljapurkar V, Dhar H, Panwar A, DCruz A K. Head and neck cancers in India. J Surg Oncol. 2017; 115:555–563.
  • Dhar H, Thiagarajan S . Anomalous Radial Artery Bifurcation – Case report of 2 cases encountered during Radial Artery Forearm Flap Harvest. Images in Surgery, 2017.
  • Dhar H, Deshmukh A. Basic Principles in Laser Surgery -Chapter in Handbook of Laser Surgery, published by Lumenis, October 2015.
  • Deshmukh A, Mair M, Dhar H Surgeries for Tongue Cancer -chapter in Atlas of Operative Surgical Oncology, 2016 (published by the Tata Memorial Hospital).
  • DCruz A K , Dhar H , Mair M , Stack B . Elective Neck Dissection in the Upper Aerodigestive Tract. Chapter in Journal of ENT Master Class special edition.
  • Dabholkar J, Sharma A, Virmani N, Dhar H. Management of benign laryngotracheal stenosis – A 5-year experience of Indian tertiary care setup. J Head Neck Physicians Surg 2018; 6:3542.
  • D'Cruz AK, Vaish R, Dhar H. Oral cancers: Current status. Oral Oncol. 2018 Dec; 87:64-69.
  • Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.Fatehi KS, Thiagarajan S, Dhar H, Purandare N, DCruz AK, Chaukar D, Laskar SG, Prabhash K, Rangarajan V.Auris Nasus Larynx. 2018 Dec 26. pii: S0385-8146(18)30620-5.
  • Thiagarajan S, Dhar H, Bhattacharjee A, et al. Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to NeoAdjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral Oncol. 2020;100:104455. doi:10.1016/j.oraloncology.2019.104455.
  • Dhar H, Vaish R, D'Cruz AK. Management of locally advanced oral cancers. Oral Oncol. 2020;105:104662. doi:10.1016/j.oraloncology.2020.104662.
  • Dhar, H., Thiagarajan, S., Yousuf, A. et al. Referral Practice for Radioactive Iodine Ablation. (RAI) after ATA guidelines 2015: results from a Tertiary Cancer Care Centre. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-05946-4.
  • Dhar H, Datta S. Experience of treating head and neck cancers in government and private health-care systems during the COVID-19 pandemic: A viewpoint with summary of existing guidelines. Cancer Res Stat Treat 2020;3, Suppl S1:123-6.
  • Balaji, A., Thiagarajan, S., Dhar, H. et al. The results of sequential swallowing assessments after total laryngectomy for laryngeal and hypopharyngeal malignancies. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-06105-5.
  • S Thiagarajan , A Yousuf , R Shetty , H Dhar , Y Mathur , D Nair , S Basu , A Patil , S Kane , S Ghosh-Laskar , D Chaukar. Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care centre . Eur Arch Otorhinolaryngol. 2020;277(6):1807‐1814.
  • Chapter: Elective Versus Therapeutic Neck Dissection for Clinically.Node Negative Early oral Cancer, D’Cruz A K, Dhar H, Vaish R .Difficult Decisions in Head and Neck Oncologic Surgery edited by Zhen Gooi, Nishant Agrawal, Springer 2019.

    Languages Spoken

  • English
  • Hindi
  • Bengali
  • Marathi
  • Tamil

    • Overview

  • Dr. Harsh Dhar is a Senior Consultant in the Department of Head and Neck Surgery at Manipal Hospitals, E.M Bypass, Kolkata, with an extensive background in the field of Head Neck Oncology and a reputation for clinical excellence. His academic journey began with an MBBS degree from a prestigious medical institution, followed by an MS in ENT and an MCh in Head and Neck Surgery from the prestigious Tata Memorial Hospital , Mumbai . In addition , he has also trained extensively in the field of Skull Base Surgery , with clinical observerships from Univ of Pittsburgh , USA and Univ of Brescia , Italy.

  • Dr. Dhar’s unwavering commitment to his field is evident from his multiple accolades, including a Gold Medal in Surgical Oncology (Batch of 2017) and Silver Medals in ENT and Internal Medicine as well as numerous publications during his academic tenure. His memberships in esteemed professional bodies such as the Foundation of Head and Neck Oncology, the Indian Society of Thyroid Surgeons, the Asia Pacific Thyroid Society, and the European Society of Medical Oncology underscore his dedication to staying at the forefront of advancements in head and neck surgery.

  • His expertise encompasses the treatment and surgical management of oral, salivary, thyroid, and sinonasal cancers, especially tumours of the skull base as well as paragangliomas. Locally advanced thyroid cancers and Endoscopic Skull base surgeries are his prime areas of expertise . With a commitment to bringing better care through technological advancements, he and his team are the first in the region to bring in intra operative nerve monitoring routinely in thyroid surgeries as well as establish a state of the art Skull Base surgical unit.

  • Beyond clinical practice, Dr. Dhar is passionate about education and within and is responsible for training many junior surgeons at his centre and through invited talks at national and regional conferences, contributing to knowledge dissemination in his specialty. With over a decade of experience, Dr. Dhar has become a trusted name in the management of complex oncological cases involving the head and neck region.

    • Fellowship & Membership

  • Member of the Foundation of Head and Neck Oncology
  • Member of the Indian Society of Thyroid Surgeons
  • Member of the Asia Pacific Thyroid Society
  • Member of the European Society of Medical Oncology

    • Field of Expertise

  • All Types of Head and Neck Malignancies
  • Thyroid Tumors

    • Awards & Achievements

  • Gold Medal in Surgical Oncology, Batch of 2017, Tata Memorial Hospital
  • Silver Medal in ENT, MBBS (III Year)
  • MUHS Silver Medicine in MS ENT
  • MGR Medical University Silver Medal in Internal Medicine -Batch of 2009

    • Talks & Publications

  • Dr. Dhar has actively contributed to clinical research, with a focus on Neoadjuvant Chemotherapy in Oral Malignancies. His work supports organ preservation strategies and improves the quality of life for cancer patients.
  • Lodha JV1, Dabholkar JP, Dhar H ; Fronto-ethmoid osteoma: addressing surgical challenges. J Postgrad Med. 2014 Apr-Jun;60(2):207-8. PMID:24823529.
  • Dhar H, Dabholkar JP, Kandalkar BM, Ghodke R. Primary thyroid schwannoma masquerading as a thyroid nodule. J Surg Case Rep. 2014 Sep 23;2014(9) PMID: 25249001.
  • Tuljapurkar V, Dhar H, Mishra A, Chakraborti S, Chaturvedi P, Pai PS. The Indian scenario of head and neck oncology – Challenging the dogmas. South Asian Journal of Cancer. 2016;5(3):105-110.
  • Vaish R, Dhar H, DCruz A K .“Beyond Me, Too”. Journal of Global Oncology 2, no. 4 (August 2016) 248-249.
  • Dandekar M, Tuljapurkar V, Dhar H, Panwar A, DCruz A K. Head and neck cancers in India. J Surg Oncol. 2017; 115:555–563.
  • Dhar H, Thiagarajan S . Anomalous Radial Artery Bifurcation – Case report of 2 cases encountered during Radial Artery Forearm Flap Harvest. Images in Surgery, 2017.
  • Dhar H, Deshmukh A. Basic Principles in Laser Surgery -Chapter in Handbook of Laser Surgery, published by Lumenis, October 2015.
  • Deshmukh A, Mair M, Dhar H Surgeries for Tongue Cancer -chapter in Atlas of Operative Surgical Oncology, 2016 (published by the Tata Memorial Hospital).
  • DCruz A K , Dhar H , Mair M , Stack B . Elective Neck Dissection in the Upper Aerodigestive Tract. Chapter in Journal of ENT Master Class special edition.
  • Dabholkar J, Sharma A, Virmani N, Dhar H. Management of benign laryngotracheal stenosis – A 5-year experience of Indian tertiary care setup. J Head Neck Physicians Surg 2018; 6:3542.
  • D'Cruz AK, Vaish R, Dhar H. Oral cancers: Current status. Oral Oncol. 2018 Dec; 87:64-69.
  • Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.Fatehi KS, Thiagarajan S, Dhar H, Purandare N, DCruz AK, Chaukar D, Laskar SG, Prabhash K, Rangarajan V.Auris Nasus Larynx. 2018 Dec 26. pii: S0385-8146(18)30620-5.
  • Thiagarajan S, Dhar H, Bhattacharjee A, et al. Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to NeoAdjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral Oncol. 2020;100:104455. doi:10.1016/j.oraloncology.2019.104455.
  • Dhar H, Vaish R, D'Cruz AK. Management of locally advanced oral cancers. Oral Oncol. 2020;105:104662. doi:10.1016/j.oraloncology.2020.104662.
  • Dhar, H., Thiagarajan, S., Yousuf, A. et al. Referral Practice for Radioactive Iodine Ablation. (RAI) after ATA guidelines 2015: results from a Tertiary Cancer Care Centre. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-05946-4.
  • Dhar H, Datta S. Experience of treating head and neck cancers in government and private health-care systems during the COVID-19 pandemic: A viewpoint with summary of existing guidelines. Cancer Res Stat Treat 2020;3, Suppl S1:123-6.
  • Balaji, A., Thiagarajan, S., Dhar, H. et al. The results of sequential swallowing assessments after total laryngectomy for laryngeal and hypopharyngeal malignancies. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-06105-5.
  • S Thiagarajan , A Yousuf , R Shetty , H Dhar , Y Mathur , D Nair , S Basu , A Patil , S Kane , S Ghosh-Laskar , D Chaukar. Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care centre . Eur Arch Otorhinolaryngol. 2020;277(6):1807‐1814.
  • Chapter: Elective Versus Therapeutic Neck Dissection for Clinically.Node Negative Early oral Cancer, D’Cruz A K, Dhar H, Vaish R .Difficult Decisions in Head and Neck Oncologic Surgery edited by Zhen Gooi, Nishant Agrawal, Springer 2019.

    Field of Expertise

  • All Types of Head and Neck Malignancies
  • Thyroid Tumors

    • Fellowship & Membership

  • Member of the Foundation of Head and Neck Oncology
  • Member of the Indian Society of Thyroid Surgeons
  • Member of the Asia Pacific Thyroid Society
  • Member of the European Society of Medical Oncology

    • Languages Spoken

  • English
  • Hindi
  • Bengali
  • Marathi
  • Tamil

    • Awards & Achievements

  • Gold Medal in Surgical Oncology, Batch of 2017, Tata Memorial Hospital
  • Silver Medal in ENT, MBBS (III Year)
  • MUHS Silver Medicine in MS ENT
  • MGR Medical University Silver Medal in Internal Medicine -Batch of 2009

    • Talks & Publications

  • Dr. Dhar has actively contributed to clinical research, with a focus on Neoadjuvant Chemotherapy in Oral Malignancies. His work supports organ preservation strategies and improves the quality of life for cancer patients.
  • Lodha JV1, Dabholkar JP, Dhar H ; Fronto-ethmoid osteoma: addressing surgical challenges. J Postgrad Med. 2014 Apr-Jun;60(2):207-8. PMID:24823529.
  • Dhar H, Dabholkar JP, Kandalkar BM, Ghodke R. Primary thyroid schwannoma masquerading as a thyroid nodule. J Surg Case Rep. 2014 Sep 23;2014(9) PMID: 25249001.
  • Tuljapurkar V, Dhar H, Mishra A, Chakraborti S, Chaturvedi P, Pai PS. The Indian scenario of head and neck oncology – Challenging the dogmas. South Asian Journal of Cancer. 2016;5(3):105-110.
  • Vaish R, Dhar H, DCruz A K .“Beyond Me, Too”. Journal of Global Oncology 2, no. 4 (August 2016) 248-249.
  • Dandekar M, Tuljapurkar V, Dhar H, Panwar A, DCruz A K. Head and neck cancers in India. J Surg Oncol. 2017; 115:555–563.
  • Dhar H, Thiagarajan S . Anomalous Radial Artery Bifurcation – Case report of 2 cases encountered during Radial Artery Forearm Flap Harvest. Images in Surgery, 2017.
  • Dhar H, Deshmukh A. Basic Principles in Laser Surgery -Chapter in Handbook of Laser Surgery, published by Lumenis, October 2015.
  • Deshmukh A, Mair M, Dhar H Surgeries for Tongue Cancer -chapter in Atlas of Operative Surgical Oncology, 2016 (published by the Tata Memorial Hospital).
  • DCruz A K , Dhar H , Mair M , Stack B . Elective Neck Dissection in the Upper Aerodigestive Tract. Chapter in Journal of ENT Master Class special edition.
  • Dabholkar J, Sharma A, Virmani N, Dhar H. Management of benign laryngotracheal stenosis – A 5-year experience of Indian tertiary care setup. J Head Neck Physicians Surg 2018; 6:3542.
  • D'Cruz AK, Vaish R, Dhar H. Oral cancers: Current status. Oral Oncol. 2018 Dec; 87:64-69.
  • Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.Fatehi KS, Thiagarajan S, Dhar H, Purandare N, DCruz AK, Chaukar D, Laskar SG, Prabhash K, Rangarajan V.Auris Nasus Larynx. 2018 Dec 26. pii: S0385-8146(18)30620-5.
  • Thiagarajan S, Dhar H, Bhattacharjee A, et al. Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to NeoAdjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral Oncol. 2020;100:104455. doi:10.1016/j.oraloncology.2019.104455.
  • Dhar H, Vaish R, D'Cruz AK. Management of locally advanced oral cancers. Oral Oncol. 2020;105:104662. doi:10.1016/j.oraloncology.2020.104662.
  • Dhar, H., Thiagarajan, S., Yousuf, A. et al. Referral Practice for Radioactive Iodine Ablation. (RAI) after ATA guidelines 2015: results from a Tertiary Cancer Care Centre. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-05946-4.
  • Dhar H, Datta S. Experience of treating head and neck cancers in government and private health-care systems during the COVID-19 pandemic: A viewpoint with summary of existing guidelines. Cancer Res Stat Treat 2020;3, Suppl S1:123-6.
  • Balaji, A., Thiagarajan, S., Dhar, H. et al. The results of sequential swallowing assessments after total laryngectomy for laryngeal and hypopharyngeal malignancies. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-06105-5.
  • S Thiagarajan , A Yousuf , R Shetty , H Dhar , Y Mathur , D Nair , S Basu , A Patil , S Kane , S Ghosh-Laskar , D Chaukar. Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care centre . Eur Arch Otorhinolaryngol. 2020;277(6):1807‐1814.
  • Chapter: Elective Versus Therapeutic Neck Dissection for Clinically.Node Negative Early oral Cancer, D’Cruz A K, Dhar H, Vaish R .Difficult Decisions in Head and Neck Oncologic Surgery edited by Zhen Gooi, Nishant Agrawal, Springer 2019.

    • Overview

  • Dr. Harsh Dhar is a Senior Consultant in the Department of Head and Neck Surgery at Manipal Hospitals, E.M Bypass, Kolkata, with an extensive background in the field of Head Neck Oncology and a reputation for clinical excellence. His academic journey began with an MBBS degree from a prestigious medical institution, followed by an MS in ENT and an MCh in Head and Neck Surgery from the prestigious Tata Memorial Hospital , Mumbai . In addition , he has also trained extensively in the field of Skull Base Surgery , with clinical observerships from Univ of Pittsburgh , USA and Univ of Brescia , Italy.

  • Dr. Dhar’s unwavering commitment to his field is evident from his multiple accolades, including a Gold Medal in Surgical Oncology (Batch of 2017) and Silver Medals in ENT and Internal Medicine as well as numerous publications during his academic tenure. His memberships in esteemed professional bodies such as the Foundation of Head and Neck Oncology, the Indian Society of Thyroid Surgeons, the Asia Pacific Thyroid Society, and the European Society of Medical Oncology underscore his dedication to staying at the forefront of advancements in head and neck surgery.

  • His expertise encompasses the treatment and surgical management of oral, salivary, thyroid, and sinonasal cancers, especially tumours of the skull base as well as paragangliomas. Locally advanced thyroid cancers and Endoscopic Skull base surgeries are his prime areas of expertise . With a commitment to bringing better care through technological advancements, he and his team are the first in the region to bring in intra operative nerve monitoring routinely in thyroid surgeries as well as establish a state of the art Skull Base surgical unit.

  • Beyond clinical practice, Dr. Dhar is passionate about education and within and is responsible for training many junior surgeons at his centre and through invited talks at national and regional conferences, contributing to knowledge dissemination in his specialty. With over a decade of experience, Dr. Dhar has become a trusted name in the management of complex oncological cases involving the head and neck region.

    Awards & Achievements

  • Gold Medal in Surgical Oncology, Batch of 2017, Tata Memorial Hospital
  • Silver Medal in ENT, MBBS (III Year)
  • MUHS Silver Medicine in MS ENT
  • MGR Medical University Silver Medal in Internal Medicine -Batch of 2009

    • Fellowship & Membership

  • Member of the Foundation of Head and Neck Oncology
  • Member of the Indian Society of Thyroid Surgeons
  • Member of the Asia Pacific Thyroid Society
  • Member of the European Society of Medical Oncology

    • Field of Expertise

  • All Types of Head and Neck Malignancies
  • Thyroid Tumors

    • Languages Spoken

  • English
  • Hindi
  • Bengali
  • Marathi
  • Tamil

    • Talks & Publications

  • Dr. Dhar has actively contributed to clinical research, with a focus on Neoadjuvant Chemotherapy in Oral Malignancies. His work supports organ preservation strategies and improves the quality of life for cancer patients.
  • Lodha JV1, Dabholkar JP, Dhar H ; Fronto-ethmoid osteoma: addressing surgical challenges. J Postgrad Med. 2014 Apr-Jun;60(2):207-8. PMID:24823529.
  • Dhar H, Dabholkar JP, Kandalkar BM, Ghodke R. Primary thyroid schwannoma masquerading as a thyroid nodule. J Surg Case Rep. 2014 Sep 23;2014(9) PMID: 25249001.
  • Tuljapurkar V, Dhar H, Mishra A, Chakraborti S, Chaturvedi P, Pai PS. The Indian scenario of head and neck oncology – Challenging the dogmas. South Asian Journal of Cancer. 2016;5(3):105-110.
  • Vaish R, Dhar H, DCruz A K .“Beyond Me, Too”. Journal of Global Oncology 2, no. 4 (August 2016) 248-249.
  • Dandekar M, Tuljapurkar V, Dhar H, Panwar A, DCruz A K. Head and neck cancers in India. J Surg Oncol. 2017; 115:555–563.
  • Dhar H, Thiagarajan S . Anomalous Radial Artery Bifurcation – Case report of 2 cases encountered during Radial Artery Forearm Flap Harvest. Images in Surgery, 2017.
  • Dhar H, Deshmukh A. Basic Principles in Laser Surgery -Chapter in Handbook of Laser Surgery, published by Lumenis, October 2015.
  • Deshmukh A, Mair M, Dhar H Surgeries for Tongue Cancer -chapter in Atlas of Operative Surgical Oncology, 2016 (published by the Tata Memorial Hospital).
  • DCruz A K , Dhar H , Mair M , Stack B . Elective Neck Dissection in the Upper Aerodigestive Tract. Chapter in Journal of ENT Master Class special edition.
  • Dabholkar J, Sharma A, Virmani N, Dhar H. Management of benign laryngotracheal stenosis – A 5-year experience of Indian tertiary care setup. J Head Neck Physicians Surg 2018; 6:3542.
  • D'Cruz AK, Vaish R, Dhar H. Oral cancers: Current status. Oral Oncol. 2018 Dec; 87:64-69.
  • Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.Fatehi KS, Thiagarajan S, Dhar H, Purandare N, DCruz AK, Chaukar D, Laskar SG, Prabhash K, Rangarajan V.Auris Nasus Larynx. 2018 Dec 26. pii: S0385-8146(18)30620-5.
  • Thiagarajan S, Dhar H, Bhattacharjee A, et al. Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to NeoAdjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral Oncol. 2020;100:104455. doi:10.1016/j.oraloncology.2019.104455.
  • Dhar H, Vaish R, D'Cruz AK. Management of locally advanced oral cancers. Oral Oncol. 2020;105:104662. doi:10.1016/j.oraloncology.2020.104662.
  • Dhar, H., Thiagarajan, S., Yousuf, A. et al. Referral Practice for Radioactive Iodine Ablation. (RAI) after ATA guidelines 2015: results from a Tertiary Cancer Care Centre. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-05946-4.
  • Dhar H, Datta S. Experience of treating head and neck cancers in government and private health-care systems during the COVID-19 pandemic: A viewpoint with summary of existing guidelines. Cancer Res Stat Treat 2020;3, Suppl S1:123-6.
  • Balaji, A., Thiagarajan, S., Dhar, H. et al. The results of sequential swallowing assessments after total laryngectomy for laryngeal and hypopharyngeal malignancies. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-06105-5.
  • S Thiagarajan , A Yousuf , R Shetty , H Dhar , Y Mathur , D Nair , S Basu , A Patil , S Kane , S Ghosh-Laskar , D Chaukar. Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care centre . Eur Arch Otorhinolaryngol. 2020;277(6):1807‐1814.
  • Chapter: Elective Versus Therapeutic Neck Dissection for Clinically.Node Negative Early oral Cancer, D’Cruz A K, Dhar H, Vaish R .Difficult Decisions in Head and Neck Oncologic Surgery edited by Zhen Gooi, Nishant Agrawal, Springer 2019.

    • Overview

  • Dr. Harsh Dhar is a Senior Consultant in the Department of Head and Neck Surgery at Manipal Hospitals, E.M Bypass, Kolkata, with an extensive background in the field of Head Neck Oncology and a reputation for clinical excellence. His academic journey began with an MBBS degree from a prestigious medical institution, followed by an MS in ENT and an MCh in Head and Neck Surgery from the prestigious Tata Memorial Hospital , Mumbai . In addition , he has also trained extensively in the field of Skull Base Surgery , with clinical observerships from Univ of Pittsburgh , USA and Univ of Brescia , Italy.

  • Dr. Dhar’s unwavering commitment to his field is evident from his multiple accolades, including a Gold Medal in Surgical Oncology (Batch of 2017) and Silver Medals in ENT and Internal Medicine as well as numerous publications during his academic tenure. His memberships in esteemed professional bodies such as the Foundation of Head and Neck Oncology, the Indian Society of Thyroid Surgeons, the Asia Pacific Thyroid Society, and the European Society of Medical Oncology underscore his dedication to staying at the forefront of advancements in head and neck surgery.

  • His expertise encompasses the treatment and surgical management of oral, salivary, thyroid, and sinonasal cancers, especially tumours of the skull base as well as paragangliomas. Locally advanced thyroid cancers and Endoscopic Skull base surgeries are his prime areas of expertise . With a commitment to bringing better care through technological advancements, he and his team are the first in the region to bring in intra operative nerve monitoring routinely in thyroid surgeries as well as establish a state of the art Skull Base surgical unit.

  • Beyond clinical practice, Dr. Dhar is passionate about education and within and is responsible for training many junior surgeons at his centre and through invited talks at national and regional conferences, contributing to knowledge dissemination in his specialty. With over a decade of experience, Dr. Dhar has become a trusted name in the management of complex oncological cases involving the head and neck region.

    Talks & Publications

  • Dr. Dhar has actively contributed to clinical research, with a focus on Neoadjuvant Chemotherapy in Oral Malignancies. His work supports organ preservation strategies and improves the quality of life for cancer patients.
  • Lodha JV1, Dabholkar JP, Dhar H ; Fronto-ethmoid osteoma: addressing surgical challenges. J Postgrad Med. 2014 Apr-Jun;60(2):207-8. PMID:24823529.
  • Dhar H, Dabholkar JP, Kandalkar BM, Ghodke R. Primary thyroid schwannoma masquerading as a thyroid nodule. J Surg Case Rep. 2014 Sep 23;2014(9) PMID: 25249001.
  • Tuljapurkar V, Dhar H, Mishra A, Chakraborti S, Chaturvedi P, Pai PS. The Indian scenario of head and neck oncology – Challenging the dogmas. South Asian Journal of Cancer. 2016;5(3):105-110.
  • Vaish R, Dhar H, DCruz A K .“Beyond Me, Too”. Journal of Global Oncology 2, no. 4 (August 2016) 248-249.
  • Dandekar M, Tuljapurkar V, Dhar H, Panwar A, DCruz A K. Head and neck cancers in India. J Surg Oncol. 2017; 115:555–563.
  • Dhar H, Thiagarajan S . Anomalous Radial Artery Bifurcation – Case report of 2 cases encountered during Radial Artery Forearm Flap Harvest. Images in Surgery, 2017.
  • Dhar H, Deshmukh A. Basic Principles in Laser Surgery -Chapter in Handbook of Laser Surgery, published by Lumenis, October 2015.
  • Deshmukh A, Mair M, Dhar H Surgeries for Tongue Cancer -chapter in Atlas of Operative Surgical Oncology, 2016 (published by the Tata Memorial Hospital).
  • DCruz A K , Dhar H , Mair M , Stack B . Elective Neck Dissection in the Upper Aerodigestive Tract. Chapter in Journal of ENT Master Class special edition.
  • Dabholkar J, Sharma A, Virmani N, Dhar H. Management of benign laryngotracheal stenosis – A 5-year experience of Indian tertiary care setup. J Head Neck Physicians Surg 2018; 6:3542.
  • D'Cruz AK, Vaish R, Dhar H. Oral cancers: Current status. Oral Oncol. 2018 Dec; 87:64-69.
  • Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.Fatehi KS, Thiagarajan S, Dhar H, Purandare N, DCruz AK, Chaukar D, Laskar SG, Prabhash K, Rangarajan V.Auris Nasus Larynx. 2018 Dec 26. pii: S0385-8146(18)30620-5.
  • Thiagarajan S, Dhar H, Bhattacharjee A, et al. Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to NeoAdjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral Oncol. 2020;100:104455. doi:10.1016/j.oraloncology.2019.104455.
  • Dhar H, Vaish R, D'Cruz AK. Management of locally advanced oral cancers. Oral Oncol. 2020;105:104662. doi:10.1016/j.oraloncology.2020.104662.
  • Dhar, H., Thiagarajan, S., Yousuf, A. et al. Referral Practice for Radioactive Iodine Ablation. (RAI) after ATA guidelines 2015: results from a Tertiary Cancer Care Centre. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-05946-4.
  • Dhar H, Datta S. Experience of treating head and neck cancers in government and private health-care systems during the COVID-19 pandemic: A viewpoint with summary of existing guidelines. Cancer Res Stat Treat 2020;3, Suppl S1:123-6.
  • Balaji, A., Thiagarajan, S., Dhar, H. et al. The results of sequential swallowing assessments after total laryngectomy for laryngeal and hypopharyngeal malignancies. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-06105-5.
  • S Thiagarajan , A Yousuf , R Shetty , H Dhar , Y Mathur , D Nair , S Basu , A Patil , S Kane , S Ghosh-Laskar , D Chaukar. Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care centre . Eur Arch Otorhinolaryngol. 2020;277(6):1807‐1814.
  • Chapter: Elective Versus Therapeutic Neck Dissection for Clinically.Node Negative Early oral Cancer, D’Cruz A K, Dhar H, Vaish R .Difficult Decisions in Head and Neck Oncologic Surgery edited by Zhen Gooi, Nishant Agrawal, Springer 2019.

    • Overview

  • Dr. Harsh Dhar is a Senior Consultant in the Department of Head and Neck Surgery at Manipal Hospitals, E.M Bypass, Kolkata, with an extensive background in the field of Head Neck Oncology and a reputation for clinical excellence. His academic journey began with an MBBS degree from a prestigious medical institution, followed by an MS in ENT and an MCh in Head and Neck Surgery from the prestigious Tata Memorial Hospital , Mumbai . In addition , he has also trained extensively in the field of Skull Base Surgery , with clinical observerships from Univ of Pittsburgh , USA and Univ of Brescia , Italy.

  • Dr. Dhar’s unwavering commitment to his field is evident from his multiple accolades, including a Gold Medal in Surgical Oncology (Batch of 2017) and Silver Medals in ENT and Internal Medicine as well as numerous publications during his academic tenure. His memberships in esteemed professional bodies such as the Foundation of Head and Neck Oncology, the Indian Society of Thyroid Surgeons, the Asia Pacific Thyroid Society, and the European Society of Medical Oncology underscore his dedication to staying at the forefront of advancements in head and neck surgery.

  • His expertise encompasses the treatment and surgical management of oral, salivary, thyroid, and sinonasal cancers, especially tumours of the skull base as well as paragangliomas. Locally advanced thyroid cancers and Endoscopic Skull base surgeries are his prime areas of expertise . With a commitment to bringing better care through technological advancements, he and his team are the first in the region to bring in intra operative nerve monitoring routinely in thyroid surgeries as well as establish a state of the art Skull Base surgical unit.

  • Beyond clinical practice, Dr. Dhar is passionate about education and within and is responsible for training many junior surgeons at his centre and through invited talks at national and regional conferences, contributing to knowledge dissemination in his specialty. With over a decade of experience, Dr. Dhar has become a trusted name in the management of complex oncological cases involving the head and neck region.

    • Fellowship & Membership

  • Member of the Foundation of Head and Neck Oncology
  • Member of the Indian Society of Thyroid Surgeons
  • Member of the Asia Pacific Thyroid Society
  • Member of the European Society of Medical Oncology

    • Field of Expertise

  • All Types of Head and Neck Malignancies
  • Thyroid Tumors

    • Languages Spoken

  • English
  • Hindi
  • Bengali
  • Marathi
  • Tamil

    • Awards & Achievements

  • Gold Medal in Surgical Oncology, Batch of 2017, Tata Memorial Hospital
  • Silver Medal in ENT, MBBS (III Year)
  • MUHS Silver Medicine in MS ENT
  • MGR Medical University Silver Medal in Internal Medicine -Batch of 2009

FAQ's

Patients visit Dr. Harsh Dhar, a leading Senior Consultant - Surgical Oncologist at Manipal Hospitals EM Bypass - Kolkata, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Dr. Harsh Dhar is a trusted choice for exceptional medical support.

Home Em-bypass Doctors Dr-harsh-dhar-oncologist

Appointment
Health Check
Contact Us
review icon
Review Us
Call Us